Landmark-based morphometric and meristic variations of endangered mrigal carp, Cirrhinus cirrhosus (Bloch 1795), from wild and hatchery stocks

Wild stocks of endangered mrigal carp, Cirrhinus cirrhosus (Bloch 1795), continues to decline rapidly in the Indo-Ganges river basin. With an objective to evaluate its population status, landmark-based morphometric and meristic variations among three different stocks viz., hatchery (Jessore), baor (Gopalganj) and river (Faridpur) in Bangladesh were studied. Significant differences were observed in 10 of the 15 morphometric measurements viz., head length, standard length, fork length, length of base of spinous, pre-orbital length, eye length, post-orbital length, length of upper jaw, height of pelvic fin and barbel length, two of the 8 meristic counts viz., scales above the lateral line and pectoral fin rays and 10 of the 22 truss network measurements viz., 1 to 10, 2 to 3, 2 to 8, 2 to 9, 2 to 10, 3 to 4, 3 to 8, 4 to 5, 4 to 7 and 9 to 10 among the stocks. For morphometric and landmark measurements, the 1st discriminant function (DF) accounted for 58.1% and the 2nd DF accounted for 41.9% of the among-group variability. In discriminant space, the river stock was isolated from the other two stocks. On the other hand, baor and hatchery stocks formed a very compact cluster. A dendrogram based on the hierarchical cluster analysis using morphometric and truss distance data placed the hatchery and baor in one cluster and the river in another cluster and the distance between the river and hatchery populations was the highest. Morphological differences among stocks are expected, because of their geographical isolation and their origin from different ancestors. The baseline information derived from the present study would be useful for genetic studies and in the assessment of environmental impacts on C. cirrhosus populations in Bangladesh

Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients

Background & Aims There is controversy regarding the role of the type 2 immune response in the pathogenesis of ulcerative colitis (UC)?few data are available from treatment-naive patients. We investigated whether genes associated with a type 2 immune response in the intestinal mucosa are up-regulated in treatment-naive pediatric patients with UC compared with patients with Crohn's disease (CD)-associated colitis or without inflammatory bowel disease (IBD), and whether expression levels are associated with clinical outcomes. Methods We used a real-time reverse-transcription quantitative polymerase chain reaction array to analyze messenger RNA (mRNA) expression patterns in rectal mucosal samples from 138 treatment-naive pediatric patients with IBD and macroscopic rectal disease, as well as those from 49 children without IBD (controls), enrolled in a multicenter prospective observational study from 2008 to 2012. Results were validated in real-time reverse-transcription quantitative polymerase chain reaction analyses of rectal RNA from an independent cohort of 34 pediatric patients with IBD and macroscopic rectal disease and 17 controls from Cincinnati Children's Hospital Medical Center. Results We measured significant increases in mRNAs associated with a type 2 immune response (interleukin [IL]5 gene, IL13, and IL13RA2) and a type 17 immune response (IL17A and IL23) in mucosal samples from patients with UC compared with patients with colon-only CD. In a regression model, increased expression of IL5 and IL17A mRNAs distinguished patients with UC from patients with colon-only CD (P =.001; area under the receiver operating characteristic curve, 0.72). We identified a gene expression pattern in rectal tissues of patients with UC, characterized by detection of IL13 mRNA, that predicted clinical response to therapy after 6 months (odds ratio [OR], 6.469; 95% confidence interval [CI], 1.553?26.94), clinical response after 12 months (OR, 6.125; 95% CI, 1.330?28.22), and remission after 12 months (OR, 5.333; 95% CI, 1.132?25.12). Conclusions In an analysis of rectal tissues from treatment-naive pediatric patients with IBD, we observed activation of a type 2 immune response during the early course of UC. We were able to distinguish patients with UC from those with colon-only CD based on increased mucosal expression of genes that mediate type 2 and type 17 immune responses. Increased expression at diagnosis of genes that mediate a type 2 immune response is associated with response to therapy and remission in pediatric patients with UC